Rationale, Design, and Methods of the Study of Comparison of Canagliflozin vs. Teneligliptin Against Basic Metabolic Risks in Patients with Type 2 Diabetes Mellitus (CANTABILE study): Protocol for a Randomized, Parallel-Group Comparison Trial

MLA

Yoshihiro Miyamoto, et al. “Rationale, Design, and Methods of the Study of Comparison of Canagliflozin vs. Teneligliptin Against Basic Metabolic Risks in Patients with Type 2 Diabetes Mellitus (CANTABILE Study): Protocol for a Randomized, Parallel-Group Comparison Trial.” Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders, vol. 11, no. 1, Sept. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7a64c48edfd658a2b47b3a9430f9d332&authtype=sso&custid=ns315887.

APA

Yoshihiro Miyamoto, Tomohiro Tanaka, Masato Kasahara, Noriko Satoh-Asahara, Toru Kusakabe, Kiminori Hosoda, Kunihiro Nishimura, Shu Kasama, & Cheol Son. (2019). Rationale, Design, and Methods of the Study of Comparison of Canagliflozin vs. Teneligliptin Against Basic Metabolic Risks in Patients with Type 2 Diabetes Mellitus (CANTABILE study): Protocol for a Randomized, Parallel-Group Comparison Trial. Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders, 11(1).

Chicago

Yoshihiro Miyamoto, Tomohiro Tanaka, Masato Kasahara, Noriko Satoh-Asahara, Toru Kusakabe, Kiminori Hosoda, Kunihiro Nishimura, Shu Kasama, and Cheol Son. 2019. “Rationale, Design, and Methods of the Study of Comparison of Canagliflozin vs. Teneligliptin Against Basic Metabolic Risks in Patients with Type 2 Diabetes Mellitus (CANTABILE Study): Protocol for a Randomized, Parallel-Group Comparison Trial.” Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders 11 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7a64c48edfd658a2b47b3a9430f9d332&authtype=sso&custid=ns315887.